Tychan to Start COVID-19 Phase 3 Clinical Trial For Novel Monoclonal Antibody TY027,

In October 2020, approval from Health Sciences Authority of Singapore (HSA) was obtained for the Phase 3 clinical trial to begin as part of the …, In October 2020, approval from Health Sciences Authority of Singapore (HSA) was obtained for the Phase 3 clinical trial to begin as part of the …, Read More

Scroll to Top